8.96
-0.34 (-3.66%)
-0.34 (-3.66%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sorrento Therapeutics Inc | SRNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.34 | -3.66% | 8.96 | 19:59:56 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 8.89 | 8.88 | 9.49 | 9.47 | 9.30 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 8.95 | 8.98 | 0.03 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 46,404 | 13,093,757 | $ 9.11 | $ 119,248,071 | 28,950,444 | 1.45 - 21.26 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:55 | formt | 392 | $ 8.96 | USD |
Sorrento Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.35B | 261.74M | 256.95M | $ 31.43M | $ - | -2.20 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Sorrento Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRNE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.28 | 12.31 | 8.88 | 10.56 | 22,696,286 | -2.32 | -20.57% |
| 1 Month | 9.03 | 12.31 | 8.80 | 10.72 | 24,344,676 | -0.07 | -0.78% |
| 3 Months | 7.39 | 21.26 | 5.77 | 11.26 | 42,036,318 | 1.57 | 21.24% |
| 6 Months | 2.44 | 21.26 | 2.18 | 8.72 | 37,113,330 | 6.52 | 267.21% |
| 1 Year | 1.53 | 21.26 | 1.45 | 7.91 | 22,024,300 | 7.43 | 485.62% |
| 3 Years | 2.60 | 21.26 | 1.39 | 7.46 | 8,726,915 | 6.36 | 244.62% |
| 5 Years | 8.73 | 21.26 | 1.39 | 7.33 | 5,439,420 | 0.23 | 2.63% |
Sorrento Therapeutics Description
| Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates. |
